Federated Hermes’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-743
Closed -$1K 2317
2022
Q3
$1K Buy
+743
New +$1.09K ﹤0.01% 2118
2017
Q4
Sell
-325
Closed -$2K 2248
2017
Q3
$2K Buy
+325
New +$2.08K ﹤0.01% 2059

Other funds holding PLXP

Federated Hermes's PLXP Position: Q4 2022 in Review

Federated Hermes sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 743 shares — an estimated $1K sold.

Federated Hermes first reported a position in PLXP in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q3 2017. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • Federated Hermes reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Federated Hermes sold 743 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Federated Hermes first reported a position in PLx Pharma Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Federated Hermes's PLx Pharma Inc. Common Stock position peaked at $2K in Q3 2017.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.